Sign In
Buy NMTC
$1.69
-0.0100 (-0.588%)
At Close: Jul 31, 2026
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
04:30pm, Thursday, 07'th Dec 2023
EDEN PRAIRIE, Minn., Dec. 07, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
08:00am, Thursday, 16'th Nov 2023
Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes
Volker strengthens existing management team in areas of commercialization, business development, and reimbursement
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
09:30am, Friday, 13'th Oct 2023
EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
04:00pm, Wednesday, 06'th Sep 2023
EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgic
NeuroOne Medical Technologies Corporation (NMTC) Q3 2023 Earnings Call Transcript
07:26pm, Monday, 14'th Aug 2023
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financi
NeuroOne Medical Technologies Corporation (NMTC) Q2 2023 Earnings Call Transcript
08:48pm, Friday, 12'th May 2023
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
12:17pm, Thursday, 11'th May 2023
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10
09:00am, Friday, 05'th May 2023
EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne Medical Technologies Corporation (NMTC) Q1 2023 Earnings Call Transcript
06:09pm, Tuesday, 14'th Feb 2023
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q1 2023 Earnings Conference Call February 14, 2023 4:30 AM ET Company Participants Dave Rosa - President and CEO Ron McClurg - CFO Conference C
NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
09:00am, Thursday, 08'th Dec 2022
EDEN PRAIRIE, Minn. , Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca
Best Penny Stocks To Buy Now? 5 Biotech Stocks To Watch This Week
12:59pm, Monday, 21'st Nov 2022
Biotech penny stocks to watch this week. Are they a buy now?
NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q3 2022 Results - Earnings Call Transcript
06:12am, Sunday, 14'th Aug 2022
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2022 Earnings Conference Call August 11, 2022 5:30 PM ET Company Participants Dave Rosa - President and Chief Executive Officer Ron McClurg
EDEN PRAIRIE, Minn. , May 19, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q2 2022 Results - Earnings Call Transcript
11:20am, Saturday, 14'th May 2022
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Dave Rosa – Chief Executive Officer Ron Mcclurg – Chief Finan
